Atromid-S for the reduction of plasma lipids.
D000738:Androsterone / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D000924:Anticholesteremic Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D002087:Butyrates / Q000494:pharmacology / Q000627:therapeutic use*; D002319:Cardiovascular System / Q000187:drug effects; D002784:Cholesterol; D004036:Diet, Atherogenic; D005989:Glycerides / Q000097:blood*; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D010743:Phospholipids / Q000097:blood*; D014280:Triglycerides / Q000097:blood
D000924:Anticholesteremic Agents; D002087:Butyrates; D005989:Glycerides; D010743:Phospholipids; D014280:Triglycerides; D002784:Cholesterol; D000738:Androsterone